814 related articles for article (PubMed ID: 9344351)
1. Color vision defect type and spatial vision in the optic neuritis treatment trial.
Schneck ME; Haegerstrom-Portnoy G
Invest Ophthalmol Vis Sci; 1997 Oct; 38(11):2278-89. PubMed ID: 9344351
[TBL] [Abstract][Full Text] [Related]
2. The dyschromatopsia of optic neuritis: a descriptive analysis of data from the optic neuritis treatment trial.
Katz B
Trans Am Ophthalmol Soc; 1995; 93():685-708. PubMed ID: 8719696
[TBL] [Abstract][Full Text] [Related]
3. The National Eye Institute Visual Function Questionnaire: experience of the ONTT. Optic Neuritis Treatment Trial.
Cole SR; Beck RW; Moke PS; Gal RL; Long DT
Invest Ophthalmol Vis Sci; 2000 Apr; 41(5):1017-21. PubMed ID: 10752936
[TBL] [Abstract][Full Text] [Related]
4. The dyschromatopsia of optic neuritis is determined in part by the foveal/perifoveal distribution of visual field damage.
Silverman SE; Hart WM; Gordon MO; Kilo C
Invest Ophthalmol Vis Sci; 1990 Sep; 31(9):1895-902. PubMed ID: 2211035
[TBL] [Abstract][Full Text] [Related]
5. Tilted disc syndrome and colour vision.
Vuori ML; Mäntyjärvi M
Acta Ophthalmol Scand; 2007 Sep; 85(6):648-52. PubMed ID: 17403021
[TBL] [Abstract][Full Text] [Related]
6. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group.
Beck RW; Cleary PA; Anderson MM; Keltner JL; Shults WT; Kaufman DI; Buckley EG; Corbett JJ; Kupersmith MJ; Miller NR
N Engl J Med; 1992 Feb; 326(9):581-8. PubMed ID: 1734247
[TBL] [Abstract][Full Text] [Related]
7. Color vision in dominant optic atrophy.
Mäntyjärvi MI; Nerdrum K; Tuppurainen K
J Clin Neuroophthalmol; 1992 Jun; 12(2):98-103. PubMed ID: 1629378
[TBL] [Abstract][Full Text] [Related]
8. Farnsworth-Munsell 100-hue test for patients with diabetes mellitus.
Utku D; Atmaca LS
Ann Ophthalmol; 1992 Jun; 24(6):205-8. PubMed ID: 1444079
[TBL] [Abstract][Full Text] [Related]
9. A differential color flicker test for detecting acquired color vision impairment in multiple sclerosis and diabetic retinopathy.
Gregori B; Papazachariadis O; Farruggia A; Accornero N
J Neurol Sci; 2011 Jan; 300(1-2):130-4. PubMed ID: 20875905
[TBL] [Abstract][Full Text] [Related]
10. A double-blind, randomized trial of IV immunoglobulin treatment in acute optic neuritis.
Roed HG; Langkilde A; Sellebjerg F; Lauritzen M; Bang P; Mørup A; Frederiksen JL
Neurology; 2005 Mar; 64(5):804-10. PubMed ID: 15753413
[TBL] [Abstract][Full Text] [Related]
11. Contrast sensitivity and other vision tests in the optic neuritis treatment trial.
Trobe JD; Beck RW; Moke PS; Cleary PA
Am J Ophthalmol; 1996 May; 121(5):547-53. PubMed ID: 8610798
[TBL] [Abstract][Full Text] [Related]
12. Detection of color vision defects in chloroquine retinopathy.
Vu BL; Easterbrook M; Hovis JK
Ophthalmology; 1999 Sep; 106(9):1799-803; discussion 1804. PubMed ID: 10485553
[TBL] [Abstract][Full Text] [Related]
13. Color vision defects in pigmentary retinal dystrophy.
Okajima O; Tanino T; Okamoto M
Jpn J Ophthalmol; 1982; 26(3):292-301. PubMed ID: 6984101
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a significantly shorter version of the Farnsworth-Munsell 100-hue test in patients with three different optic neuropathies.
Nichols BE; Thompson HS; Stone EM
J Neuroophthalmol; 1997 Mar; 17(1):1-6. PubMed ID: 9093953
[TBL] [Abstract][Full Text] [Related]
15. Visual function at baseline and 1 month in acute optic neuritis: predictors of visual outcome.
Kupersmith MJ; Gal RL; Beck RW; Xing D; Miller N;
Neurology; 2007 Aug; 69(6):508-14. PubMed ID: 17679669
[TBL] [Abstract][Full Text] [Related]
16. Chromatic and luminance losses with multiple sclerosis and optic neuritis measured using dynamic random luminance contrast noise.
Flanagan P; Zele AJ
Ophthalmic Physiol Opt; 2004 May; 24(3):225-33. PubMed ID: 15130171
[TBL] [Abstract][Full Text] [Related]
17. [Pratical remarks on Farnsworth 100 Hue in acquired dyschromatopsies].
Biais B; Guile Y
Arch Ophtalmol (Paris); 1976 Feb; 36(2):147-54. PubMed ID: 132919
[No Abstract] [Full Text] [Related]
18. A new colour vision test for clinical use.
Kon CH; De Alwis D
Eye (Lond); 1996; 10 ( Pt 1)():65-74. PubMed ID: 8763306
[TBL] [Abstract][Full Text] [Related]
19. Visual function 5 years after optic neuritis: experience of the Optic Neuritis Treatment Trial. The Optic Neuritis Study Group.
Arch Ophthalmol; 1997 Dec; 115(12):1545-52. PubMed ID: 9400788
[TBL] [Abstract][Full Text] [Related]
20. Visual functions following recovery from non-arteritic central retinal artery occlusion.
Landa E; Rehany U; Rumelt S
Ophthalmic Surg Lasers Imaging; 2004; 35(2):103-8. PubMed ID: 15088819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
